Apyx medical corporation to release fourth quarter and fiscal year 2023 financial results on march 21, 2024

Clearwater, fla.--(business wire)--apyx® medical corporation (nasdaq:apyx) (the “company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as renuvion®, today announced that financial results for the fourth quarter and fiscal year 2023 will be released before the market opens on thursday, march 21st. management will host a conference call at 8:00 a.m. eastern time on march 21st to discuss the results of the quarter and year, and to host a questio.
APYX Ratings Summary
APYX Quant Ranking